文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人乳脂蛋白脂肪酶对人极低密度脂蛋白的脂解降解:将脂蛋白B鉴定为主要的脂蛋白降解产物。

Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.

作者信息

Alaupovic P, Wang C S, McConathy W J, Weiser D, Downs D

出版信息

Arch Biochem Biophys. 1986 Jan;244(1):226-37. doi: 10.1016/0003-9861(86)90112-8.


DOI:10.1016/0003-9861(86)90112-8
PMID:3080947
Abstract

Although the direct conversion of very low density lipoproteins (VLDL) into low density (LDL) and high density (HDL) lipoproteins only requires lipoprotein lipase (LPL) as a catalyst and albumin as the fatty acid acceptor, the in vitro-formed LDL and HDL differ chemically from their native counterparts. To investigate the reason(s) for these differences, VLDL were treated with human milk LPL in the presence of albumin, and the LPL-generated LDL1-, LDL2-, and HDL-like particles were characterized by lipid and apolipoprotein composition. Results showed that the removal of apolipoproteins B, C, and E from VLDL was proportional to the degree of triglyceride hydrolysis with LDL2 particles as the major and LDL1 and HDL + VHDL particles as the minor products of a complete in vitro lipolysis of VLDL. In comparison with native counterparts, the in vitro-formed LDL2 and HDL + VHDL were characterized by lower levels of triglyceride and cholesterol ester and higher levels of free cholesterol and lipid phosphorus. The characterization of lipoprotein particles present in the in vitro-produced LDL2 showed that, as in plasma LDL2, lipoprotein B (LP-B) was the major apolipoprotein B-containing lipoprotein accounting for over 90% of the total apolipoprotein B. Other, minor species of apolipoprotein B-containing lipoproteins included LP-B:C-I:E and LP-B:C-I:C-II:C-III. The lipid composition of in vitro-formed LP-B closely resembled that of plasma LP-B. The major parts of apolipoproteins C and E present in VLDL were released to HDL + VHDL as simple, cholesterol/phospholipid-rich lipoproteins including LP-C-I, LP-C-II, LP-C-III, and LP-E. However, some of these same simple lipoprotein particles were present after ultracentrifugation in the LDL2 density segment because of their hydrated density and/or because they formed, in the absence of naturally occurring acceptors (LP-A-I:A-II), weak associations with LP-B. Thus, the presence of varying amounts of these cholesterol/phospholipid-rich lipoproteins in the in vitro-formed LDL2 appears to be the main reason for their compositional difference from native LDL2. These results demonstrate that the formation of LP-B as the major apolipoprotein B-containing product of VLDL lipolysis only requires LPL as a catalyst and albumin as the fatty acid acceptor. However, under physiological circumstances, other modulating agents are necessary to prevent the accumulation and interaction of phospholipid/cholesterol-rich apolipoprotein C- and E-containing particles.

摘要

尽管极低密度脂蛋白(VLDL)直接转化为低密度脂蛋白(LDL)和高密度脂蛋白(HDL)仅需要脂蛋白脂肪酶(LPL)作为催化剂以及白蛋白作为脂肪酸受体,但体外形成的LDL和HDL在化学性质上与它们的天然对应物有所不同。为了探究这些差异的原因,在白蛋白存在的情况下,用人乳LPL处理VLDL,并通过脂质和载脂蛋白组成对LPL产生的LDL1、LDL2以及类似HDL的颗粒进行表征。结果表明,从VLDL中去除载脂蛋白B、C和E与甘油三酯水解程度成正比,LDL2颗粒是VLDL完全体外脂解的主要产物,LDL1和HDL + VHDL颗粒是次要产物。与天然对应物相比,体外形成的LDL2和HDL + VHDL的特点是甘油三酯和胆固醇酯水平较低,游离胆固醇和脂质磷水平较高。对体外产生的LDL2中存在的脂蛋白颗粒进行表征发现,与血浆LDL2一样,脂蛋白B(LP - B)是主要的含载脂蛋白B的脂蛋白,占总载脂蛋白B的90%以上。其他含载脂蛋白B的脂蛋白的次要种类包括LP - B:C - I:E和LP - B:C - I:C - II:C - III。体外形成的LP - B的脂质组成与血浆LP - B非常相似。VLDL中存在的载脂蛋白C和E的主要部分以简单的、富含胆固醇/磷脂的脂蛋白形式释放到HDL + VHDL中,包括LP - C - I、LP - C - II、LP - C - III和LP - E。然而,由于它们的水合密度和/或因为它们在缺乏天然存在的受体(LP - A - I:A - II)的情况下与LP - B形成了弱结合,在超速离心后的LDL2密度段中也存在一些相同的简单脂蛋白颗粒。因此,体外形成的LDL2中存在不同数量的这些富含胆固醇/磷脂的脂蛋白似乎是其与天然LDL2组成差异的主要原因。这些结果表明,形成作为VLDL脂解主要含载脂蛋白B产物的LP - B仅需要LPL作为催化剂以及白蛋白作为脂肪酸受体。然而,在生理情况下,需要其他调节剂来防止富含磷脂/胆固醇的含载脂蛋白C和E颗粒的积累和相互作用。

相似文献

[1]
Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.

Arch Biochem Biophys. 1986-1

[2]
Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.

Atherosclerosis. 1995-12

[3]
Impact of phosphatidylcholine liposomes on the compositional changes of VLDL during lipoprotein lipase (LPL)-mediated lipolysis.

Chem Phys Lipids. 2016-2

[4]
Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.

Kidney Int. 2002-1

[5]
Lipolysis-induced degradation of apolipoproteins B and E of human very low density lipoproteins.

J Biol Chem. 1986-2-25

[6]
Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.

Biochim Biophys Acta. 1996-10-18

[7]
The role of different albumin preparations on production of human plasma lipoprotein-like particles in vitro.

J Lipid Res. 1980-5

[8]
Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.

J Lipid Res. 1991-6

[9]
Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.

Biochemistry. 1987-7-28

[10]
Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.

J Lipid Res. 1981-5

引用本文的文献

[1]
Influence of peripheral artery disease and statin therapy on apolipoprotein profiles.

Int J Vasc Med. 2013

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索